DK3908570T3 - Ketaminpamoat og andevendelse deraf - Google Patents
Ketaminpamoat og andevendelse deraf Download PDFInfo
- Publication number
- DK3908570T3 DK3908570T3 DK20739053.5T DK20739053T DK3908570T3 DK 3908570 T3 DK3908570 T3 DK 3908570T3 DK 20739053 T DK20739053 T DK 20739053T DK 3908570 T3 DK3908570 T3 DK 3908570T3
- Authority
- DK
- Denmark
- Prior art keywords
- ketamine pamoate
- pamoate
- ketamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
- C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962791058P | 2019-01-11 | 2019-01-11 | |
| US201962871763P | 2019-07-09 | 2019-07-09 | |
| PCT/CN2020/071404 WO2020143762A1 (en) | 2019-01-11 | 2020-01-10 | Ketamine pamoate and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3908570T3 true DK3908570T3 (da) | 2024-02-26 |
Family
ID=71521952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK20739053.5T DK3908570T3 (da) | 2019-01-11 | 2020-01-10 | Ketaminpamoat og andevendelse deraf |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US11981617B2 (da) |
| EP (1) | EP3908570B1 (da) |
| JP (1) | JP7451538B2 (da) |
| KR (1) | KR102892857B1 (da) |
| CN (1) | CN113423686B (da) |
| AU (1) | AU2020206826B2 (da) |
| CL (1) | CL2021001803A1 (da) |
| CO (1) | CO2021006884A2 (da) |
| DK (1) | DK3908570T3 (da) |
| ES (1) | ES2974259T3 (da) |
| FI (1) | FI3908570T3 (da) |
| HR (1) | HRP20240255T1 (da) |
| HU (1) | HUE065684T2 (da) |
| LT (1) | LT3908570T (da) |
| MX (1) | MX2021006029A (da) |
| MY (1) | MY203905A (da) |
| PE (1) | PE20211550A1 (da) |
| PH (1) | PH12021551157A1 (da) |
| PL (1) | PL3908570T3 (da) |
| PT (1) | PT3908570T (da) |
| RS (1) | RS65271B1 (da) |
| SG (1) | SG11202104792SA (da) |
| SI (1) | SI3908570T1 (da) |
| SM (1) | SMT202400100T1 (da) |
| TW (1) | TWI827783B (da) |
| WO (1) | WO2020143762A1 (da) |
| ZA (1) | ZA202103132B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3043785T1 (sl) | 2013-09-13 | 2022-02-28 | National University Corporation Chiba University | Uporaba R-ketamina in njegove soli kot farmacevtska sredstva |
| PL3505157T3 (pl) | 2017-12-29 | 2022-04-11 | Celon Pharma S.A. | Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie |
| JP7548669B2 (ja) | 2018-02-15 | 2024-09-10 | 国立大学法人千葉大学 | 炎症性疾患若しくは骨疾患の予防又は治療剤及び医薬組成物 |
| AU2019262197B2 (en) | 2018-05-04 | 2024-12-19 | Perception Neuroscience, Inc. | Methods of treating substance abuse |
| EP4076410B1 (en) * | 2019-12-20 | 2025-09-10 | Alar Pharmaceuticals Inc. | Long-acting injectable formulations of ketamine pamoate salts |
| US20210322669A1 (en) * | 2020-04-16 | 2021-10-21 | Invictus Health, Inc. | Method for treatment of traumatic brain injuries |
| CN112263572A (zh) * | 2020-11-17 | 2021-01-26 | 厦门大学附属翔安医院 | 右旋氯胺酮在制备治疗脱髓鞘疾病药物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001051919A2 (en) * | 2000-01-07 | 2001-07-19 | Transform Pharmaceuticals, Inc. | High-throughput formation, identification, and analysis of diverse solid-forms |
| US20080293695A1 (en) * | 2007-05-22 | 2008-11-27 | David William Bristol | Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance |
| US9421266B2 (en) * | 2007-05-22 | 2016-08-23 | Pisgah Laboratories, Inc. | Safety of pseudoephedrine drug products |
| JO2857B1 (en) * | 2008-06-16 | 2015-03-15 | سانوفي أفينتس | Vinyl pipers with modified activity of tumor-resistant TNF |
| JO3227B1 (ar) * | 2011-09-08 | 2018-03-08 | Otsuka Pharma Co Ltd | مشتقات بنزو ثيوفين بها استبدال ببرازين كعوامل مضادة للذهان |
| JP2014196292A (ja) | 2013-03-07 | 2014-10-16 | 大塚製薬株式会社 | 医薬 |
| CN106562952B (zh) * | 2015-10-09 | 2020-06-09 | 江阴安博生物医药有限公司 | 氯胺酮在治疗重性抑郁障碍中的应用 |
| WO2017167180A1 (zh) | 2016-03-29 | 2017-10-05 | 上海华汇拓医药科技有限公司 | 沃替西汀的帕莫酸盐及其晶型 |
| KR102442753B1 (ko) * | 2016-12-26 | 2022-09-16 | 셀릭스 바이오 프라이빗 리미티드 | 만성 통증 치료를 위한 화합물 |
| IL275968B2 (en) * | 2018-01-10 | 2024-07-01 | Xwpharma Ltd | Prodrugs of ketamine, compositions and uses thereof |
-
2020
- 2020-01-10 HR HRP20240255TT patent/HRP20240255T1/hr unknown
- 2020-01-10 SG SG11202104792SA patent/SG11202104792SA/en unknown
- 2020-01-10 LT LTEPPCT/CN2020/071404T patent/LT3908570T/lt unknown
- 2020-01-10 US US17/421,407 patent/US11981617B2/en active Active
- 2020-01-10 AU AU2020206826A patent/AU2020206826B2/en active Active
- 2020-01-10 TW TW109100921A patent/TWI827783B/zh active
- 2020-01-10 KR KR1020217025339A patent/KR102892857B1/ko active Active
- 2020-01-10 PT PT207390535T patent/PT3908570T/pt unknown
- 2020-01-10 EP EP20739053.5A patent/EP3908570B1/en active Active
- 2020-01-10 FI FIEP20739053.5T patent/FI3908570T3/fi active
- 2020-01-10 ES ES20739053T patent/ES2974259T3/es active Active
- 2020-01-10 PE PE2021000756A patent/PE20211550A1/es unknown
- 2020-01-10 RS RS20240215A patent/RS65271B1/sr unknown
- 2020-01-10 WO PCT/CN2020/071404 patent/WO2020143762A1/en not_active Ceased
- 2020-01-10 MY MYPI2021003518A patent/MY203905A/en unknown
- 2020-01-10 HU HUE20739053A patent/HUE065684T2/hu unknown
- 2020-01-10 JP JP2021540341A patent/JP7451538B2/ja active Active
- 2020-01-10 DK DK20739053.5T patent/DK3908570T3/da active
- 2020-01-10 PL PL20739053.5T patent/PL3908570T3/pl unknown
- 2020-01-10 SM SM20240100T patent/SMT202400100T1/it unknown
- 2020-01-10 CN CN202080007207.5A patent/CN113423686B/zh active Active
- 2020-01-10 MX MX2021006029A patent/MX2021006029A/es unknown
- 2020-01-10 SI SI202030367T patent/SI3908570T1/sl unknown
-
2021
- 2021-05-10 ZA ZA2021/03132A patent/ZA202103132B/en unknown
- 2021-05-20 PH PH12021551157A patent/PH12021551157A1/en unknown
- 2021-05-25 CO CONC2021/0006884A patent/CO2021006884A2/es unknown
- 2021-07-07 CL CL2021001803A patent/CL2021001803A1/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3932919T3 (da) | Jak-inhibitorforbindelse og anvendelse deraf | |
| IL285178A (en) | Compounds and uses thereof | |
| DK3917616T3 (da) | Heterocykliske forbindelser og anvendelse deraf | |
| IL280915A (en) | Single-chain chimeric polypeptides and uses thereof | |
| DK3870579T3 (da) | Tyk2-inhibitorer og anvendelser deraf | |
| DK3908570T3 (da) | Ketaminpamoat og andevendelse deraf | |
| DK3784283T3 (da) | Cannabidiopræparater og anvendelser deraf | |
| DK3753937T3 (da) | Atr-hæmmer og anvendelse deraf | |
| IL285461A (en) | Processes and compounds | |
| DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
| DK3877052T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK3877376T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK3543240T3 (da) | URAT1-inhibitor og anvendelse deraf | |
| DK3621694T3 (da) | Lrrc33-inhibitorer og anvendelse heraf | |
| DK3892621T3 (da) | Haloallylaminforbindelser og anvendelse deraf | |
| DK4034535T3 (da) | Aza-quinolinforbindelser og anvendelser deraf | |
| EP3741758A4 (en) | BROMODOMAIN INHIBITOR COMPOUND AND ITS USE | |
| DK4043460T3 (da) | Antiproliferationsforbindelser og anvendelser deraf | |
| DK3919498T6 (da) | Pyrrolopyrimidinderivat og anvendelse deraf | |
| IL286622A (en) | Prmt5 inhibitors and uses thereof | |
| DK3737399T5 (da) | Atf5-peptidvarianter og anvendelser deraf | |
| EP4017857A4 (en) | METTL 16 INHIBITORS AND THEIR USES | |
| DK3932909T3 (da) | Benzoindazolonforbindelse og mellemprodukt heraf | |
| DK3573611T3 (da) | Amidforbindelser og anvendelse deraf | |
| DK3983387T3 (da) | Sulfonylurinstofderivater og anvendelser deraf |